Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | PDPK1 | O15530 | 14/20 | 0.45 |
| ▸ | AURKA | O14965 | 5/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 5/20 | 0.41 |
| ▸ | AURKB | Q96GD4 | 5/20 | 0.41 |
| ▸ | SGK1 | O00141 | 4/20 | 0.41 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.41 |
| ▸ | CHUK | O15111 | 1/20 | 0.41 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | JAK3 | P52333 | 1/20 | 0.41 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | BCR | P11274 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25934856 | 0.82 | JAK2 (0.44) | JAK2PDPK1AURKATGFBR1AURKB | |
| SCHEMBL25933243 | 0.77 | JAK2 (0.62) | JAK2PDPK1AURKATGFBR1AURKB | |
| SCHEMBL24137787 | 0.71 | JAK2 (0.61) | JAK2PDPK1AURKATGFBR1AURKB | |
| SCHEMBL6480460 | 0.70 | PDPK1 (0.65) | JAK2PDPK1AURKATGFBR1AURKB | |
| SCHEMBL24137503 | 0.69 | MAP2K4 (0.55) | JAK2PDPK1AURKATGFBR1AURKB | |
| SCHEMBL24137502 | 0.69 | JAK2 (0.48) | JAK2PDPK1AURKATGFBR1AURKB | |
| SCHEMBL25933239 | 0.69 | ABL1 (0.54) | JAK2PDPK1AURKATGFBR1AURKB | |
| SCHEMBL24137844 | 0.67 | MKNK1 (0.58) | JAK2PDPK1SGK1RPS6KB1ABL1 | |
| SCHEMBL6478095 | 0.67 | JAK2 (0.59) | JAK2PDPK1AURKATGFBR1AURKB | |
| SCHEMBL25933254 | 0.67 | BTK (0.50) | JAK2PDPK1AURKATGFBR1AURKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234935-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234935-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | PACSIN2, MAP3K20, PHKG1 | JAK2 228/4885PDPK1 123/4885AURKA 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.